2,759
Views
14
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: Supportive care

Risk of hyperglycemia attributable to everolimus in cancer patients: A meta-analysis

, &
Pages 1196-1203 | Received 21 Oct 2015, Accepted 05 Mar 2016, Published online: 04 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lingaku Lee, Tetsuhide Ito & Robert T. Jensen. (2018) Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence. Expert Opinion on Pharmacotherapy 19:8, pages 909-928.
Read now

Articles from other publishers (13)

N. Silvestris, T. Franchina, M. Gallo, A. Argentiero, A. Avogaro, G. Cirino, A. Colao, R. Danesi, G. Di Cianni, S. D’Oronzo, A. Faggiano, S. Fogli, D. Giuffrida, S. Gori, N. Marrano, R. Mazzilli, M. Monami, M. Montagnani, L. Morviducci, A. Natalicchio, A. Ragni, V. Renzelli, A. Russo, L. Sciacca, E. Tuveri, M.C. Zatelli, F. Giorgino & S. Cinieri. (2023) Diabetes management in cancer patients. An Italian Association of Medical Oncology, Italian Association of Medical Diabetologists, Italian Society of Diabetology, Italian Society of Endocrinology and Italian Society of Pharmacology multidisciplinary consensus position paper. ESMO Open 8:6, pages 102062.
Crossref
Jaydira Del Rivero, Kimberly Perez, Erin B. Kennedy, Erik S. Mittra, Namrata Vijayvergia, Junaid Arshad, Sandip Basu, Aman Chauhan, Arvind N. Dasari, Andrew M. Bellizzi, Alexandra Gangi, Erin Grady, James R. Howe, Jana Ivanidze, Mark Lewis, Josh Mailman, Nitya Raj, Heloisa P. Soares, Michael C. Soulen, Sarah B. White, Jennifer A. Chan, Pamela L. Kunz, Simron Singh, Thorvardur R. Halfdanarson, Jonathan R. Strosberg & Emily K. Bergsland. (2023) Systemic Therapy for Tumor Control in Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline. Journal of Clinical Oncology 41:32, pages 5049-5067.
Crossref
Junqiang J. Tian, Mark Levy, Xuekai Zhang, Robert Sinnott & Rolando Maddela. (2022) Counteracting health risks by Modulating Homeostatic Signaling. Pharmacological Research 182, pages 106281.
Crossref
Lin Yang, Zhixin Zhang, Doudou Wang, Yu Jiang & Ying Liu. (2022) Targeting mTOR Signaling in Type 2 Diabetes Mellitus and Diabetes Complications. Current Drug Targets 23:7, pages 692-710.
Crossref
Nalinie Joharatnam‐Hogan, Pinkie Chambers, Ketan Dhatariya & Ruth Board. (2021) A guideline for the outpatient management of glycaemic control in people with cancer. Diabetic Medicine 39:1.
Crossref
Christoph Hertzberg & David Neal Franz. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 3721 3751 .
Rabia K. Shahid, Shahid Ahmed, Duc Le & Sunil Yadav. (2021) Diabetes and Cancer: Risk, Challenges, Management and Outcomes. Cancers 13:22, pages 5735.
Crossref
Matteo Monami, Lara Naletto, Besmir Nreu, Ilaria Dicembrini, Giorgio Sesti & Edoardo Mannucci. (2020) Immune checkpoints inhibitors and hyperglycemia: A Meta-analysis of randomized controlled trials. Diabetes Research and Clinical Practice 162, pages 108115.
Crossref
Christoph Hertzberg & David Neal Franz. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy 1 32 .
David A. Pattison, Lisa L. MacFarlane, Jason Callahan, Emma L. Kane, Timothy Akhurst & Rodney J. Hicks. (2019) Personalised insulin calculator enables safe and effective correction of hyperglycaemia prior to FDG PET/CT. EJNMMI Research 9:1.
Crossref
Mikhail V. Blagosklonny. (2019) Rapamycin for longevity: opinion article. Aging 11:19, pages 8048-8067.
Crossref
Mikhail V. Blagosklonny. (2019) Fasting and rapamycin: diabetes versus benevolent glucose intolerance. Cell Death & Disease 10:8.
Crossref
Wei-Ling Chiu, Leonid Churilov, Chee-Hau Lim, Alanna Tan, Rithin Nedumannil, Lik-Hui Lau, Jeremy Lew, Mariam Hachem, Alvin Kong, Raymond Robbins, Harvey Sutcliffe, Que Lam, Andrew Lee, Frida Djukiadmodjo, Natalie Nanayakkara, Jeffrey D. Zajac & Elif I. Ekinci. (2019) Routine HbA1c among hematology and oncology inpatients: Diabetes-status and hospital-outcomes. Diabetes Research and Clinical Practice 152, pages 71-78.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.